Browsing: real estate

Investors have a buying opportunity here with currently weak solar demand among several other headwinds. …

Morgan Stanley is bullish on pelabresib, currently awaiting results from its Phase 3 MANIFEST-2 trial. …

Here are the biggest calls on Wall Street on …

Analyst Peter Supino said the company's premium valuation does not provide enough safety to counter the rising risk of reduced growth. …

The firm lowered its rating on shares to equal weight from overweight and slashed its price target approximately 40%. …

The firm initiated coverage on Post Holdings with an overweight rating. …

Analyst Chuck Grom upgraded shares to buy from hold in a Friday note. …

Starboard Value's Jeffrey Smith, one of the busiest activist investors for two decades, said companies have grown more receptive to voices like him. …

A decline in bond prices could mean this is a great opportunity to snap up tax-exempt municipal bonds. …

Buy these call options heading into quarterly results for upside potential, according to Goldman Sachs. …

"AI is going to lead to one of the biggest improvements in productivity … which is highly anti-inflationary," Wood said at CNBC's Financial Advisor Summit. …

Banks have been feeling the pressure against the backdrop of higher interest rates, but these three names could emerge as winners this earnings season. …

JPMorgan is bullish on the company's long-term outlook despite short-term challenges. …

GLP-1 medications could have far-reaching implications for a wide variety of conditions, from liver disease to sleep apnea to heart disease. …